Skip to content Skip to footer
Close

Toxins 2024

The Toxnet group delivered a symposium on 18 January 2024 at the Toxins congress called, ‘Addressing key barriers to optimize patient-centred spasticity care’.

The symposium was opened by one of the Toxnet co-chairs, Gerard Francisco who explained why Toxnet was formed, its mission and achievements to date.

Dr Francesca Bianchi discussed recent research that has been undertaken by the group to identify and rank key barriers that can delay or prevent access to quality, evidenced-based care for patients with post-stroke spasticity.

Dr Jorge Jacinto introduced the new GO-FAST tool* that has been developed by Toxnet to support physicians with a patient-centred approach to goal-setting; a topic that has been identified as one of the key educational needs.

Finally, Dr Stefano Carda led an interactive session, involving the audience with the selection of appropriate goals using the GO-FAST tool for a spasticity patient case.

The Toxnet symposium was very well received by the Toxins audience who congratulated the group on the development of the highly practical GO-FAST tool and welcomed the introduction of future innovations by the Toxnet group to address barriers to optimal spasticity management.

* Jacinto J et al. Selecting Goals and Target Muscles for Botulinum Toxin A Injection Using the Goal Oriented Facilitated Approach to Spasticity Treatment (GO-FAST) Tool. Toxins 2023, 15, 676.

© 2024 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.